{"GHMDC classification":["Diagnosis"],"GHMDC health topic":["Maternal mortality"],"GHMDC scope":["Commercialized"],"Page SDG":["SDG09 Industry innovation and infrastructure","SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Microlife_3BTO-A"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Many women in underdeveloped countries suffer from preeclampsia.\nPreeclampsia is a condition that typically starts after the 20th week of pregnancy and is related to increased blood pressure and protein in the mother's urine (as a result of kidney problems). Preeclampsia affects the placenta, and it can affect the mother's kidney, liver, and brain. When preeclampsia causes seizures, the condition is known as eclampsia--the second leading cause of maternal death in the U.S. Preeclampsia is also a leading cause of fetal complications, which include low birth weight, premature birth, and stillbirth."],"Page image":["File:Pro bp3bto-ap f.gif"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Microlife 3BTO-A"],"Page views":[44],"Page year":["Sunday, 01-Jan-12 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:02:19 UTC"]}